Cost and cost-effectiveness of Mohs micrographic surgery versus conventional excision for nonmelanoma skin cancer: A scoping review
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: Nonmelanoma skin cancers (NMSCs) are commonly treated with conventional excision (CE) or Mohs micrographic surgery (MMS), but their relative cost-effectiveness remains uncertain. Objective: To summarize the available economic evidence comparing MMS and CE for NMSC and, secondarily, to identify methodological gaps that limit interpretation of comparative cost-effectiveness. Methods: We performed a scoping review of EMBASE, Scopus, PubMed, and Cochrane (January 11, 2025). Studies reporting costs and/or incremental cost-effectiveness between MMS and CE for NMSC were included. Results: = 1) were eligible. Reported costs ranged from $408-$3534 for MMS and $587-$2644 for CE, with directionality driven by repair complexity and care setting. Limitations: Main limitations included cross-system cost incomparability, predominance of observational designs with short horizons, inconsistent capture of downstream recurrence costs and patient-reported outcomes, and reliance on appropriate use criteria not designed for economic inference. Conclusion: Despite superior clinical margin control with MMS, inconsistent economic methods yield conflicting cost-effectiveness conclusions. Standardized, data-driven evaluations that incorporate comprehensive costs, long-term outcomes, and patient-centered measures are needed to guide the indication-specific use of MMS versus CE.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Cost and cost-effectiveness of Mohs micrographic surgery versus conventional excision for nonmelanoma skin cancer: A scoping review
- Date Crossref
- 01/08/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Roswell Park Comprehensive Cancer Center pays non établi dans la noticeStructure de recherche
-
University at Buffalo Department of Economics pays non établi dans la noticeUniversité ou école supérieure
-
University of Arizona pays non établi dans la noticeUniversité ou école supérieure
-
University of Arizona College of Medicine- Phoenix pays non établi dans la noticeUniversité ou école supérieure
-
Department of Dermatology pays non établi dans la noticeInstitution
Roswell Park Comprehensive Cancer Center, Department of Economics — University at Buffalo et University of Arizona, avec 2 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.